ArticleInvestigational new drugs2021

A retrospective comparative study of S-IROX and modified FOLFIRINOX for patients with advanced pancreatic cancer refractory to gemcitabine plus nab-paclitaxel.

Kei Saito et al.PubMed ↗Publisher ↗

No numbers read from the abstract.